Coronary artery disease trials in Bulgaria

2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 1Not yet taking people in Bulgaria
  A Study to Learn About How Safe Nitroglycerin is and How it Affects the Body When Taken Along With Nurandociguat in People With Coronary Artery Disease

  Where

  Sofia

  Age

  40 years to 80 years

  People

  36 worldwide

  Run by

  Bayer

  See details and how to joinNCT07431294 · EU 2025-522335-34-00
• Phase 2/3Taking people
  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  Where

  Dobrich, Gabrovo, Lom, Montana, Plovdiv, Sliven, Smolyan, Sofia, Stara Zagora

  Age

  18 years and over

  People

  3,110 worldwide

  Run by

  CSL Behring

  See details and how to joinNCT05485961 · EU 2022-500273-14-00